Predicting Advanced Prostate Cancer from Modeling Early Indications in Biopsy and Prostatectomy Samples via Transductive Semi-Supervised Survival Analysis

Table 5

Weights of features in models with multimodal characteristics.

	Cox Model		Cox Model with Transduction		SVRc		SVRc with Transduction
Feature	Original Weight	Normalized Weight	Original Weight	Normalized Weight	Original Weight	Normalized Weight	Original Weight	Normalized Weight
Clinical Stage	0.475	0.408	0.535	0.444	-3.083	-0.174	-6.658	-0.320
PSA	0.700	0.601	0.893	0.741	-9.763	-0.552	-15.587	-0.749
Dominant Biopsy Gleason Grade	-0.094	-0.081	0.039	0.032	-4.867	-0.275	-6.679	-0.321
Biopsy Gleason Sum	1.164	1.000	1.205	1.000	-16.801	-0.949	-20.076	-0.965
Dominant Prostatectomy Gleason Grade	0.455	0.391	0.643	0.534	-7.005	-0.396	-7.460	-0.358
Prostatectomy Gleason Sum	0.260	0.223	0.181	0.150	-14.282	-0.807	-7.011	-0.337
Seminal Vesicle Invasion	0.842	0.723	0.846	0.703	-20.542	-1.161	-24.166	-1.161
Surgical Margin Status	0.371	0.319	0.414	0.344	-4.788	-0.271	-6.757	-0.325
Extra Capsular Extension Status	0.802	0.689	0.892	0.740	-6.217	-0.351	-6.485	-0.312
AR+ Area	-1.099	-0.944	-1.026	-0.852	15.277	0.863	17.347	0.833
Cytoplasm Texture	-1.195	-1.026	-0.931	-0.773	17.699	1.000	20.814	1.000
Luminal Area	-0.467	-0.401	-0.424	-0.352	10.264	0.580	12.092	0.581
Glandular Size	0.475	0.408	0.535	0.444	-3.083	-0.174	-6.658	-0.320